Viable BC organoids were obtained from luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched and triple negative BC (TNBC; estrogen and progesterone receptors negative, HER2 negative). This evidence concerns the gene ERBB2 and breast cancer.